NYSE:EHAB - US29332G1022 - Common Stock
The current stock price of EHAB is 7.88 USD. In the past month the price increased by 20.86%. In the past year, price decreased by -6.64%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS | CVS HEALTH CORP | 11.54 | 92.78B | ||
CI | THE CIGNA GROUP | 10.71 | 80.31B | ||
LH | LABCORP HOLDINGS INC | 18.36 | 23.10B | ||
DGX | QUEST DIAGNOSTICS INC | 19.2 | 20.31B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.66 | 15.08B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.31 | 14.46B | ||
DVA | DAVITA INC | 14.22 | 9.85B | ||
HIMS | HIMS & HERS HEALTH INC | 52.94 | 9.57B | ||
GH | GUARDANT HEALTH INC | N/A | 8.41B | ||
CHE | CHEMED CORP | 20.47 | 6.67B | ||
RDNT | RADNET INC | 199.33 | 5.52B | ||
OPCH | OPTION CARE HEALTH INC | 21.24 | 4.65B |
Enhabit, Inc. functions as an investment holding company. The company is headquartered in Dallas, Texas and currently employs 10,700 full-time employees. The company went IPO on 2022-06-23. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. The company works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. The company operates about 115 hospice agencies and 255 home health agencies.
ENHABIT INC
6688 N. Central Expressway, Suite 1300
Dallas TEXAS US
Employees: 10700
Phone: 14696216419
The current stock price of EHAB is 7.88 USD. The price decreased by -0.51% in the last trading session.
The exchange symbol of ENHABIT INC is EHAB and it is listed on the New York Stock Exchange, Inc. exchange.
EHAB stock is listed on the New York Stock Exchange, Inc. exchange.
11 analysts have analysed EHAB and the average price target is 9.56 USD. This implies a price increase of 21.35% is expected in the next year compared to the current price of 7.88. Check the ENHABIT INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ENHABIT INC (EHAB) has a market capitalization of 399.44M USD. This makes EHAB a Small Cap stock.
ENHABIT INC (EHAB) currently has 10700 employees.
ENHABIT INC (EHAB) has a support level at 7.87 and a resistance level at 7.94. Check the full technical report for a detailed analysis of EHAB support and resistance levels.
The Revenue of ENHABIT INC (EHAB) is expected to grow by 2.84% in the next year. Check the estimates tab for more information on the EHAB EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EHAB does not pay a dividend.
ENHABIT INC (EHAB) will report earnings on 2025-11-04, after the market close.
The PE ratio for ENHABIT INC (EHAB) is 26.27. This is based on the reported non-GAAP earnings per share of 0.3 and the current share price of 7.88 USD. Check the full fundamental report for a full analysis of the valuation metrics for EHAB.
The outstanding short interest for ENHABIT INC (EHAB) is 3.11% of its float. Check the ownership tab for more information on the EHAB short interest.
ChartMill assigns a technical rating of 2 / 10 to EHAB. When comparing the yearly performance of all stocks, EHAB is a bad performer in the overall market: 87.51% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to EHAB. EHAB has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months EHAB reported a non-GAAP Earnings per Share(EPS) of 0.3. The EPS increased by 30.43% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -10.87% | ||
ROE | -24.11% | ||
Debt/Equity | 0.83 |
11 analysts have analysed EHAB and the average price target is 9.56 USD. This implies a price increase of 21.35% is expected in the next year compared to the current price of 7.88.
For the next year, analysts expect an EPS growth of 139.94% and a revenue growth 2.84% for EHAB